Global Age Related Macular Degeneration Drug Market Insights and Forecast to 2028

Publisher Name :
Date: 13-Jan-2022
No. of pages: 90
Inquire Before Buying

Age Related Macular Degeneration Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Age Related Macular Degeneration Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Lucentis

- Eylea

- Avastin

- Others

Segment by Application

- Hospitals

- Clinics

- Others

By Company

- Regeneron Pharmaceuticals

- Bayer HealthCare

- Novartis

- Roche

- Kanghong Pharma

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global Age Related Macular Degeneration Drug Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Age Related Macular Degeneration Drug Product Introduction
1.2 Market by Type
1.2.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Age Related Macular Degeneration Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Age Related Macular Degeneration Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Age Related Macular Degeneration Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Age Related Macular Degeneration Drug Sales by Region
2.4.1 Global Age Related Macular Degeneration Drug Sales by Region (2017-2022)
2.4.2 Global Sales Age Related Macular Degeneration Drug by Region (2023-2028)
2.5 Global Age Related Macular Degeneration Drug Revenue by Region
2.5.1 Global Age Related Macular Degeneration Drug Revenue by Region (2017-2022)
2.5.2 Global Age Related Macular Degeneration Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Age Related Macular Degeneration Drug Sales by Manufacturers
3.1.1 Global Top Age Related Macular Degeneration Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Age Related Macular Degeneration Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Age Related Macular Degeneration Drug in 2021
3.2 Global Age Related Macular Degeneration Drug Revenue by Manufacturers
3.2.1 Global Age Related Macular Degeneration Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration Drug Revenue in 2021
3.3 Global Age Related Macular Degeneration Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Age Related Macular Degeneration Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Age Related Macular Degeneration Drug Sales by Type
4.1.1 Global Age Related Macular Degeneration Drug Historical Sales by Type (2017-2022)
4.1.2 Global Age Related Macular Degeneration Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2028)
4.2 Global Age Related Macular Degeneration Drug Revenue by Type
4.2.1 Global Age Related Macular Degeneration Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Age Related Macular Degeneration Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2017-2028)
4.3 Global Age Related Macular Degeneration Drug Price by Type
4.3.1 Global Age Related Macular Degeneration Drug Price by Type (2017-2022)
4.3.2 Global Age Related Macular Degeneration Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Age Related Macular Degeneration Drug Sales by Application
5.1.1 Global Age Related Macular Degeneration Drug Historical Sales by Application (2017-2022)
5.1.2 Global Age Related Macular Degeneration Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2028)
5.2 Global Age Related Macular Degeneration Drug Revenue by Application
5.2.1 Global Age Related Macular Degeneration Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Age Related Macular Degeneration Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2017-2028)
5.3 Global Age Related Macular Degeneration Drug Price by Application
5.3.1 Global Age Related Macular Degeneration Drug Price by Application (2017-2022)
5.3.2 Global Age Related Macular Degeneration Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Age Related Macular Degeneration Drug Market Size by Type
6.1.1 North America Age Related Macular Degeneration Drug Sales by Type (2017-2028)
6.1.2 North America Age Related Macular Degeneration Drug Revenue by Type (2017-2028)
6.2 North America Age Related Macular Degeneration Drug Market Size by Application
6.2.1 North America Age Related Macular Degeneration Drug Sales by Application (2017-2028)
6.2.2 North America Age Related Macular Degeneration Drug Revenue by Application (2017-2028)
6.3 North America Age Related Macular Degeneration Drug Market Size by Country
6.3.1 North America Age Related Macular Degeneration Drug Sales by Country (2017-2028)
6.3.2 North America Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Age Related Macular Degeneration Drug Market Size by Type
7.1.1 Europe Age Related Macular Degeneration Drug Sales by Type (2017-2028)
7.1.2 Europe Age Related Macular Degeneration Drug Revenue by Type (2017-2028)
7.2 Europe Age Related Macular Degeneration Drug Market Size by Application
7.2.1 Europe Age Related Macular Degeneration Drug Sales by Application (2017-2028)
7.2.2 Europe Age Related Macular Degeneration Drug Revenue by Application (2017-2028)
7.3 Europe Age Related Macular Degeneration Drug Market Size by Country
7.3.1 Europe Age Related Macular Degeneration Drug Sales by Country (2017-2028)
7.3.2 Europe Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Age Related Macular Degeneration Drug Market Size by Type
8.1.1 Asia Pacific Age Related Macular Degeneration Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Age Related Macular Degeneration Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Age Related Macular Degeneration Drug Market Size by Application
8.2.1 Asia Pacific Age Related Macular Degeneration Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Age Related Macular Degeneration Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Age Related Macular Degeneration Drug Market Size by Region
8.3.1 Asia Pacific Age Related Macular Degeneration Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Age Related Macular Degeneration Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Age Related Macular Degeneration Drug Market Size by Type
9.1.1 Latin America Age Related Macular Degeneration Drug Sales by Type (2017-2028)
9.1.2 Latin America Age Related Macular Degeneration Drug Revenue by Type (2017-2028)
9.2 Latin America Age Related Macular Degeneration Drug Market Size by Application
9.2.1 Latin America Age Related Macular Degeneration Drug Sales by Application (2017-2028)
9.2.2 Latin America Age Related Macular Degeneration Drug Revenue by Application (2017-2028)
9.3 Latin America Age Related Macular Degeneration Drug Market Size by Country
9.3.1 Latin America Age Related Macular Degeneration Drug Sales by Country (2017-2028)
9.3.2 Latin America Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Age Related Macular Degeneration Drug Market Size by Type
10.1.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Age Related Macular Degeneration Drug Market Size by Application
10.2.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Age Related Macular Degeneration Drug Market Size by Country
10.3.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Regeneron Pharmaceuticals
11.1.1 Regeneron Pharmaceuticals Corporation Information
11.1.2 Regeneron Pharmaceuticals Overview
11.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Regeneron Pharmaceuticals Recent Developments
11.2 Bayer HealthCare
11.2.1 Bayer HealthCare Corporation Information
11.2.2 Bayer HealthCare Overview
11.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer HealthCare Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Overview
11.4.3 Roche Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Roche Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 Kanghong Pharma
11.5.1 Kanghong Pharma Corporation Information
11.5.2 Kanghong Pharma Overview
11.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kanghong Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Age Related Macular Degeneration Drug Industry Chain Analysis
12.2 Age Related Macular Degeneration Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Age Related Macular Degeneration Drug Production Mode & Process
12.4 Age Related Macular Degeneration Drug Sales and Marketing
12.4.1 Age Related Macular Degeneration Drug Sales Channels
12.4.2 Age Related Macular Degeneration Drug Distributors
12.5 Age Related Macular Degeneration Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Age Related Macular Degeneration Drug Industry Trends
13.2 Age Related Macular Degeneration Drug Market Drivers
13.3 Age Related Macular Degeneration Drug Market Challenges
13.4 Age Related Macular Degeneration Drug Market Restraints
14 Key Findings in The Global Age Related Macular Degeneration Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Age Related Macular Degeneration Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Lucentis
Table 3. Major Manufacturers of Eylea
Table 4. Major Manufacturers of Avastin
Table 5. Major Manufacturers of Others
Table 6. Global Age Related Macular Degeneration Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Age Related Macular Degeneration Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Age Related Macular Degeneration Drug Sales by Region (2017-2022) & (K Units)
Table 9. Global Age Related Macular Degeneration Drug Sales Market Share by Region (2017-2022)
Table 10. Global Age Related Macular Degeneration Drug Sales by Region (2023-2028) & (K Units)
Table 11. Global Age Related Macular Degeneration Drug Sales Market Share by Region (2023-2028)
Table 12. Global Age Related Macular Degeneration Drug Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Age Related Macular Degeneration Drug Revenue Market Share by Region (2017-2022)
Table 14. Global Age Related Macular Degeneration Drug Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Age Related Macular Degeneration Drug Revenue Market Share by Region (2023-2028)
Table 16. Global Age Related Macular Degeneration Drug Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Age Related Macular Degeneration Drug Sales Share by Manufacturers (2017-2022)
Table 18. Global Age Related Macular Degeneration Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2017-2022)
Table 20. Age Related Macular Degeneration Drug Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Age Related Macular Degeneration Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Age Related Macular Degeneration Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Drug as of 2021)
Table 23. Age Related Macular Degeneration Drug Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Age Related Macular Degeneration Drug Product Offered
Table 25. Date of Manufacturers Enter into Age Related Macular Degeneration Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 28. Global Age Related Macular Degeneration Drug Sales by Type (2023-2028) & (K Units)
Table 29. Global Age Related Macular Degeneration Drug Sales Share by Type (2017-2022)
Table 30. Global Age Related Macular Degeneration Drug Sales Share by Type (2023-2028)
Table 31. Global Age Related Macular Degeneration Drug Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Age Related Macular Degeneration Drug Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Age Related Macular Degeneration Drug Revenue Share by Type (2017-2022)
Table 34. Global Age Related Macular Degeneration Drug Revenue Share by Type (2023-2028)
Table 35. Age Related Macular Degeneration Drug Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Age Related Macular Degeneration Drug Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 38. Global Age Related Macular Degeneration Drug Sales by Application (2023-2028) & (K Units)
Table 39. Global Age Related Macular Degeneration Drug Sales Share by Application (2017-2022)
Table 40. Global Age Related Macular Degeneration Drug Sales Share by Application (2023-2028)
Table 41. Global Age Related Macular Degeneration Drug Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Age Related Macular Degeneration Drug Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Age Related Macular Degeneration Drug Revenue Share by Application (2017-2022)
Table 44. Global Age Related Macular Degeneration Drug Revenue Share by Application (2023-2028)
Table 45. Age Related Macular Degeneration Drug Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Age Related Macular Degeneration Drug Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 48. North America Age Related Macular Degeneration Drug Sales by Type (2023-2028) & (K Units)
Table 49. North America Age Related Macular Degeneration Drug Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Age Related Macular Degeneration Drug Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 52. North America Age Related Macular Degeneration Drug Sales by Application (2023-2028) & (K Units)
Table 53. North America Age Related Macular Degeneration Drug Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Age Related Macular Degeneration Drug Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Age Related Macular Degeneration Drug Sales by Country (2017-2022) & (K Units)
Table 56. North America Age Related Macular Degeneration Drug Sales by Country (2023-2028) & (K Units)
Table 57. North America Age Related Macular Degeneration Drug Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Age Related Macular Degeneration Drug Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 60. Europe Age Related Macular Degeneration Drug Sales by Type (2023-2028) & (K Units)
Table 61. Europe Age Related Macular Degeneration Drug Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Age Related Macular Degeneration Drug Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 64. Europe Age Related Macular Degeneration Drug Sales by Application (2023-2028) & (K Units)
Table 65. Europe Age Related Macular Degeneration Drug Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Age Related Macular Degeneration Drug Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Age Related Macular Degeneration Drug Sales by Country (2017-2022) & (K Units)
Table 68. Europe Age Related Macular Degeneration Drug Sales by Country (2023-2028) & (K Units)
Table 69. Europe Age Related Macular Degeneration Drug Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Age Related Macular Degeneration Drug Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Age Related Macular Degeneration Drug Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Age Related Macular Degeneration Drug Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Age Related Macular Degeneration Drug Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Age Related Macular Degeneration Drug Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Age Related Macular Degeneration Drug Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Age Related Macular Degeneration Drug Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Age Related Macular Degeneration Drug Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Age Related Macular Degeneration Drug Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Age Related Macular Degeneration Drug Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Age Related Macular Degeneration Drug Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Age Related Macular Degeneration Drug Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Age Related Macular Degeneration Drug Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Age Related Macular Degeneration Drug Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Age Related Macular Degeneration Drug Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Age Related Macular Degeneration Drug Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Age Related Macular Degeneration Drug Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Age Related Macular Degeneration Drug Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Age Related Macular Degeneration Drug Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Age Related Macular Degeneration Drug Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Age Related Macular Degeneration Drug Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Age Related Macular Degeneration Drug Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Age Related Macular Degeneration Drug Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Age Related Macular Degeneration Drug Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Age Related Macular Degeneration Drug Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Age Related Macular Degeneration Drug Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Age Related Macular Degeneration Drug Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2023-2028) & (US$ Million)
Table 107. Regeneron Pharmaceuticals Corporation Information
Table 108. Regeneron Pharmaceuticals Description and Major Businesses
Table 109. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Regeneron Pharmaceuticals Recent Developments
Table 112. Bayer HealthCare Corporation Information
Table 113. Bayer HealthCare Description and Major Businesses
Table 114. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Bayer HealthCare Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bayer HealthCare Recent Developments
Table 117. Novartis Corporation Information
Table 118. Novartis Description and Major Businesses
Table 119. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Novartis Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Novartis Recent Developments
Table 122. Roche Corporation Information
Table 123. Roche Description and Major Businesses
Table 124. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Roche Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Roche Recent Developments
Table 127. Kanghong Pharma Corporation Information
Table 128. Kanghong Pharma Description and Major Businesses
Table 129. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Kanghong Pharma Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Kanghong Pharma Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Age Related Macular Degeneration Drug Distributors List
Table 135. Age Related Macular Degeneration Drug Customers List
Table 136. Age Related Macular Degeneration Drug Market Trends
Table 137. Age Related Macular Degeneration Drug Market Drivers
Table 138. Age Related Macular Degeneration Drug Market Challenges
Table 139. Age Related Macular Degeneration Drug Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Age Related Macular Degeneration Drug Product Picture
Figure 3. Global Age Related Macular Degeneration Drug Market Share by Type in 2021 & 2028
Figure 3. Lucentis Product Picture
Figure 4. Eylea Product Picture
Figure 5. Avastin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Age Related Macular Degeneration Drug Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Age Related Macular Degeneration Drug Report Years Considered
Figure 12. Global Age Related Macular Degeneration Drug Sales 2017-2028 (K Units)
Figure 13. Global Age Related Macular Degeneration Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Age Related Macular Degeneration Drug Revenue 2017-2028 (US$ Million)
Figure 15. Global Age Related Macular Degeneration Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Age Related Macular Degeneration Drug Sales Market Share by Region (2017-2022)
Figure 17. Global Age Related Macular Degeneration Drug Sales Market Share by Region (2023-2028)
Figure 18. North America Age Related Macular Degeneration Drug Sales YoY (2017-2028) & (K Units)
Figure 19. North America Age Related Macular Degeneration Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Age Related Macular Degeneration Drug Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Age Related Macular Degeneration Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Age Related Macular Degeneration Drug Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Age Related Macular Degeneration Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Age Related Macular Degeneration Drug Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Age Related Macular Degeneration Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Age Related Macular Degeneration Drug Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Age Related Macular Degeneration Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Age Related Macular Degeneration Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Age Related Macular Degeneration Drug in the World: Market Share by Age Related Macular Degeneration Drug Revenue in 2021
Figure 30. Global Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2028)
Figure 34. Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2017-2028)
Figure 35. North America Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Age Related Macular Degeneration Drug Revenue Market Share by Type (2017-2028)
Figure 37. North America Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2028)
Figure 38. North America Age Related Macular Degeneration Drug Revenue Market Share by Application (2017-2028)
Figure 39. North America Age Related Macular Degeneration Drug Sales Share by Country (2017-2028)
Figure 40. North America Age Related Macular Degeneration Drug Revenue Share by Country (2017-2028)
Figure 41. U.S. Age Related Macular Degeneration Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Age Related Macular Degeneration Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2028)
Figure 44. Europe Age Related Macular Degeneration Drug Revenue Market Share by Type (2017-2028)
Figure 45. Europe Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Age Related Macular Degeneration Drug Revenue Market Share by Application (2017-2028)
Figure 47. Europe Age Related Macular Degeneration Drug Sales Share by Country (2017-2028)
Figure 48. Europe Age Related Macular Degeneration Drug Revenue Share by Country (2017-2028)
Figure 49. Germany Age Related Macular Degeneration Drug Revenue (2017-2028) & (US$ Million)
Figure 50. France Age Related Macular Degeneration Drug Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Age Related Macular Degeneration Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Age Related Macular Degeneration Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Age Related Macular Degeneration Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Age Related Macular Degeneration Drug Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Age Related Macular Degeneration Drug Revenue Market Share by Application (2017-2028)
Figure 58. A
  • Global Autologous Matrix-induced Chondrogenesis Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 112
    Autologous Matrix-induced Chondrogenesis market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Autologous Matrix-induced Chondrogenesis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Hyaluronic Acid - Collagen -......
  • Global Asthma and COPD Drug Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 91
    Asthma and COPD Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Asthma and COPD Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Bronchodilators - Anti-inflammatory Drugs - Monoclonal Antibodies - Combination Drug......
  • Global Anticancer Drugs Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 106
    Anticancer Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anticancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) - Targeted Drugs (Monoclonal Antibodies and Tyros......
  • Global Animal Health Care Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 88
    Animal Health Care market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Animal Health Care market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Bovine - Porcine - Ovine - Poultry Segment by Appl......
  • Global Animal Blood Plasma Products and Derivatives Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 105
    Animal Blood Plasma Products and Derivatives market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Animal Blood Plasma Products and Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Immunoglobulin - Fibrinogen - Serum Albumin......
  • Global Anesthesia Gas Blender Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 113
    Anesthesia Gas Blender market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anesthesia Gas Blender market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Manual - Electronic Segment by Application - Ambulatory Surgical Centers......
  • Global Ampoules and Syringes Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 113
    Ampoules and Syringes market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ampoules and Syringes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Ampoules - Syringes Segment by Application - Personal Care - Pharma......
  • Global Ambulatory Surgical & Emergency Center Services Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 95
    Ambulatory Surgical & Emergency Center Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Ambulatory Surgical & Emergency Center Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Primary Care Offices ......
  • Global Alpha Mannosidosis Market Insights and Forecast to 2028
    Published: 20-Jan-2022        Price: US 4900 Onwards        Pages: 71
    Alpha Mannosidosis market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Alpha Mannosidosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Bone Marrow Transplant (BMT) - Enzyme Replacement Therapy (ERT) ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs